Segmental up-regulation of transforming growth factor-β in the pathogenesis of primary megaureter. An immunocytochemical study

British Journal of Urology

Volumn 80, Issue 6, 1997, Pages 946-949

  Nicotina, P A ^a,b   Romeo, C ^a,b   Arena, F ^a,b   Romeo, G ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

Immunocytochemistry; Pathogenesis; Primary megaureter; Transforming growth factor

Indexed keywords

MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CATTLE; CHILD; CLINICAL ARTICLE; FETUS; FETUS DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFANT; MEGAURETER; MUSCLE; NONHUMAN; PRIORITY JOURNAL; URETER;

ANIMALS; CATTLE; CHILD; CHILD, PRESCHOOL; DILATATION, PATHOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; URETERAL DISEASES;

EID: 0031403319     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Keating MA, Escala J, Snyder HM et al. Changing concepts in the management of primary obstructive megaureter. J Urol 1989; 142: 636-40
2. Keating MA, Retik AB. Management of the dilated obstructed ureter. In Retik AB, ed. Pediatric Urinary Obstruction. Urol Clin North Am 1990; 17(suppl): 291-306
3. Belloli G, Campobasso P, Cappelari F, Mercurella A. Management of primary non-refluxing upper urinary tract dilation: an analysis of 219 paediatric patients. Pediatr Surg Int 1993; 8: 229-35
4. Cozzi F, Madonna L, Maggi E et al. Management of primary megaureter in infancy. J Pediatr Surg 1993; 8: 1031-3
5. Liu HYA, Dhillon HK. Yeoung CK, Diamond DA. Duffy PG, Ransley PG. Clinical outcome and management of prenatally diagnosed primary megaureters. J Urol 1994; 152: 614-7
6. Keating MA. The nonrefluxing megaureter: pathophysiology and Pathogenesis. In Ehrlich RM ed., Congenital Obstructive Megaureter: Etiology, Diagnosis and Treatment - Dialogues in Pediatric Urology, Vol.16, no. 2. New York: William Miller Associates, 1993: 2-4
7. Hanna MK, Jeffs RD, Sturgess JM, Barkin M. Ureteral structure and ultrastructure. Part III. The congenital dilated ureter (Megaureter). J Urol 1977; 117: 24-31
8. Beurton D. Le mégauretére obstructif primitif de l'enfant et de l'adulte. J d'Urol 1983; 89: 298-392
9. Arena F, Nicotina PA, Ferlazzo G, Romeo C, Gentile C. Istochimica ed immunoistochimica del danno intramurale nel eguareterre primitivo in età pediatrica. Rass It Chir Ped 1992; 34: 238-42
10. Massaguè J, Cheifetz S, Endo T, Nadal-Ginard B. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci 1986; 83: 8206-10
11. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localisation of TGF-β1, TGF-β2 and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991; 115: 1091-105
12. Blachowski S, Motyl T, Orzechowski A, Grzelkowska K, Interewicz B. Comparison of metabolic effects of EGF, TGF, and TGF-β in primary culture of fetal bovine myoblasts and rat L6 myoblasts. Int J Biochem 1993; 25: 1571-8
13. Arthur GH, Noakes GE Pearson H, Parkinson TJ eds, Veterinary Reproduction and Obstetrics, 7th edn. London: Saunders, 1996: 182-6
14. Gosling JA, Nixon JS. Functional obstruction of the ureter and renal pelvis. A histological and electron microscopy study. Br J Urol 1978; 50: 145-9
15. Tokunaka S, Gotoh T, Koyanagi T, Mijabe N. Muscle dysplasia in megaureters. J Urol 1984; 131: 383-90
16. Medel Q. Cited in Keating MA. The nonrefluxing megaureter: pathophysiology and pathogenesis. In Ehrlich RM ed., Congenital Obstructive Megaureter: Etiology, Diagnosis and Treatment - Dialogues in Pediatric Urology, Vol.16, no. 2 New York: William Miller Associates 1993: 2-4
17. Alcaraz A, Vinaixa F. Tejedo-Mateu A et al. Obstruction and recanalization of the ureter during embryonic development. J Urol 1991; 145: 410-6
18. Florini Jr, Magri KA. Effects of growth factors on myogenic differentiation. Am J Physiol 1989; 256: 701-11
19. Seremetis GM, Maizels M. TGF-β mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction. J Urol 1996; 56: 261-6
20. Ewton DZ, Spizz G, Olson EN, Florini JR. Decrease in transforming growth factor-β binding and action during differentation in muscle cells. J Biol Chem 1988; 263: 4029-32
21. Nilsen-Hamilton M. Transforming growth factor-beta and its action on cellular growth and differentiation. Curr Top Dev Biol 1990; 24: 95-136